Improvements in protease inhibitor-based HAART.
Boyle
Brian A
BA
Department of International Medicine and Infectious Disease (Courtesy), New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans
D017320:HIV Protease Inhibitors